Pulse Biosciences Inc ROCE
Was ist das ROCE von Pulse Biosciences Inc?
ROCE von Pulse Biosciences Inc ist -130.51%
Was ist die Definition von ROCE?
Die Kapitalerträge (ROCE) entsprechen einer Finanzkennzahl, die die Rentabilität eines Unternehmens und die Effizienz, mit der sein Kapital verwendet wird, misst.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Pulse Biosciences Inc
Was macht Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Unternehmen mit roce ähnlich Pulse Biosciences Inc
- International Battery Metals hat ROCE von -132.11%
- Essex Minerals hat ROCE von -131.42%
- Mojave Gold hat ROCE von -131.30%
- Helius Medical Technologies Inc hat ROCE von -130.96%
- Vivos Therapeutics hat ROCE von -130.94%
- Chicken Soup for the Soul Entertainment Inc hat ROCE von -130.72%
- Pulse Biosciences Inc hat ROCE von -130.51%
- Phivida hat ROCE von -130.09%
- Zynerba Pharmaceuticals Inc hat ROCE von -129.50%
- Shine Box Capital hat ROCE von -129.34%
- Greenrose Acquisition hat ROCE von -129.34%
- Nickel Rock Resources hat ROCE von -129.17%
- Extraction Oil & Gas hat ROCE von -129.03%